We have a competent technical team to make dossiers & complete tech transfer to the customers plant. We can assist in taking initial batches.
SR. NO. | Generic | Strengths | Dosage form | Brand | Innovator | Status of Development |
---|---|---|---|---|---|---|
1 | Amiodarone | 200mg | Tablets | Cordarone | Sanofi Winthrop | Antiarrhythmic |
2 | Amlodipine besylate & Benezepril | 2.5/10 mg, 5/10 mg, 5/20 mg, 5/40 mg, 10/20 mg and 10/40 mg | Capsules | Lotrel | Novartis Pharmaceuticals Corporation | Antihypertensive |
3 | Atomoxetine | 10, 18, 25, 40, 60, 80, or 100 mg | Capsules | Strattera | Eli Lilly and Company | Attention - Deficit/Hyperactivity Disorder (ADHD) |
4 | Azathioprine | 75 mg, 100 mg | Tablets | Azasan | AAIPharma Inc | Prevention of rejection in renal homotransplantation, rheumatoid arthritis |
5 | Atorvastatin | 10, 20, 40, 80mg | Tablets | Lipitor | Pfizer | Hypercholesterolemia |
6 | Tamsulosin HCl | 0.4 mg | Capsules | Flomax | Boehringer Ingelheim | BPH |
7 | Bromocryptine mesylate | 5mg | Capsules | Parlodel | Novartis Pharmaceuticals Corporation | Hyperprolactinemia Associated Dysfunctions |
8 | Levitiracetam | 250,500,750, 1000mg | Tablets | Keppra | UCB | Antiepileptic |
9 | Sirolimus | 0.5, 1, 2mg | Tablets | Rapamune | Wyeth Pharmaceuticals Inc | Prophylaxis in renal transfer |
10 | Ranolazine | 500, 1000 mg | Tablets | Ranexa | Gilead Sciences Inc | Antianginal |
11 | Tacrolimus | 0.5, 1, 5mg | Capsules | Prograf | Astellas | Organ rejection in kidney transfer |
12 | Topiramate | 15 mg and 25 mg | Sprinkle capsules | Topamax | Janssen Ortho, LLC | Antiepileptic |
13 | Silodosin | 4mg, 8mg | Hard Gelatin Capsules | Rapaflo® | Allergan Sales LLC | Alpha adrenergic blocker |
14 | Deferasirox | 125 mg, 250 mg, and 500 mg tablets for oral suspension | Tablets for oral suspension | Exjade® | Novartis | Chelating agent |
15 | Deferasirox | 90 mg, 180 mg, or 360 mg | Tablets | Jadenu® | Novartis | Chelating agent |
16 | Solefinacin Succinate | 5mg, 10mg | Tablets | Vesicare® | Astellas Pharma US Inc | Urinary Antispasmodics |
17 | Itraconazole | 100mg | Capsules | Sporanox® | Janssen Pharmaceuticals Inc | Azole antifungal |
18 | Sildenafil | 25mg, 50mg, 100mg | Tablets | Viagra® | Pfizer | Erectile Dysfunction Agent |
19 | Colesevelam | 625 mg, 1.875 gram single-dose packet, 1.875 gram singledose packet | Tab and Oral Suspension | Welchol® | Daiichi Sankyo Inc | Bile acid sequestrants |
20 | Modafinil | 100mg, 200mg | Tablets | Provigil | Cephalon Inc | CNS stimulant |
SR. NO. | Generic | Strengths | Dosage form | Brand | Innovator | Status of Development |
---|---|---|---|---|---|---|
1 | Clarithromycin | 250 mg/ 500 mg | Film Coated Tablet | Biaxin® | Abbvie | Ready for Pilot BE |
2 | Aripiprazole | 2mg, 5mg, 10mg, 15mg, 20mg, 30mg | Tablet | Abilify® | Otsuka America Pharm | Pilot BE due in December 2020 |
3 | Potassium Citrate | 5 meq, 10 meq, 15 meq | Tablet | Urocit K® | Mission Pharmacal | Pilot BE complete and successful |
4 | Loratadine+ Pseudoephedrine | 10mg/240mg | Tablet | Claritin D 24® | Bayer | Pilot BE complete and successful |
5 | Loperamide+ Simethicone | 2mg/125mg | Tablet | Imodium Multi Symptom Relief® | Johnson and Johnson | Pilot BE complete and successful |
6 | Mesalamine | 1.2g | DR Tablet | Lialda® | Shire | Ready for Tech transfer |
7 | Digoxin | 62.5 mcg/125 mcg/ 250 mcg | Tablet | Lanoxin® | Concordia Pharms Inc | Pilot BE complete and successful |
8 | Ezetimibe | 10 mg | Tablet | Zetia® | Merck Sharpe and Dohme | Technology Transfer underway. Pivotal BE study scheduled in December 2020 |
9 | Hydrochloroquine Sulphate | 200 mg | Tablet | Plaquenil® | Concordia Pharms Inc | Pilot BE complete and successful |
10 | Omeprazole | 10mg/20mg/40mg /80mg | Tablet | Prilosec® | Astra Zeneca | Pilot BE due in November 2020 |
11 | Metformin | 500 mg, 1000 mg | ER Tablet | Fortamet | Shionogi | Pilot BE study due in December 2020 |
12 | Mesalamine | 800mg | DR Tablet | Asacol HD® | Allergan | Pilot BE study due in January 2021 |
13 | Mesalamine | 500mg, 1gm | Suppository | Canasa® | Allergan | Pilot BE study due in January 2021 |
14 | Amoxicillin Clavulanate | 875/125 Mg, 500/ 125 Mg, 250/ 125 Mg | Tablet | Augmentin | Glaxo SmithKline | Pilot BE due in January 2021 |
15 | Azithromycin | 600mg | Tablet | Zithromax | Pfizer | Pilot BE due in December 2020 |
16 | Azithromycin | 100mg/ 5ML, 200Mg/ 5 ML | Suspension | Zithromax | Pfizer | Pilot BE due in December 2020 |
17 | Levothyroxine sodium | 12 Strengths (25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200 And 300 Mcg) | Tablet | Synthroid | Abbvie | Pilot BE in Q1 2021 |
18 | Amoxicillin Clavulanate | 250mg/5ml; Eq 62.5mg Base/5ml; 125mg/5ml; Eq 31.25mg Base/5ml | Suspension | Augmentin | DR Reddy's | Pilot BE due in January 2021 |
19 | Tenofovir, Emtricitabine, Efavirenz | 300mg, 200mg, 600mg | Tablets | Atripla | Gilead Sciences | Pilot BE due in December 2020 |
20 | Esomeprazole | 20mg | DR Capsules | Nexium 24Hrs | Astrazeneca | Pilot BE due in December 2020 |
21 | Potassium Chloride | 10meq, 20meq | ER Tablets | Klor-Con M10, KlorCon M20 | Upsher-Smith | Pilot BE due in January 2021 |
22 | Trazodone | 150mg, 300mg | ER Tablets | Oleptro | Angelini | Pilot BE study complete and successful |
23 | Trazodone | 50mg, 100mg, 150mg, 300mg | Tablets | Trazodone Hydrochloride | Apotex | Pilot BE due in February 2021 |
24 | Pseudoephedrine | 60/120 mg | ER Tablets | Sudafed | Johnson And Johnson | Pilot BE due in January 2021 |
SR. NO. | Generic | Strengths | Dosage form | Brand | Innovator | Therapeutic Category |
---|---|---|---|---|---|---|
1 | Alfuzosin | 10mg | ER tablets | Uroxatral | Sanofi-Aventis | BPH |
2 | Desvenlafaxine | 50, 100mg | ER tablets | Pristiq | Wyeth Pharmaceuticals Inc | Antidepressant |
3 | Divalproex | Eq. to 125 mg, 250 mg, or 500 mg of valproic acid. | DR tablets | Depakote | Abbott Pharmaceuticals PR Ltd. | Anticonvulsants |
4 | Duloxetine | 20, 30, 60mg | DR capsules | Cymbalta | Lily | Antidepressant |
5 | Etodolac | 400, 500, 600mg | ER tablets | Teva | Arthritis | |
6 | Memantine HCl ER & Donepezil | 7/10 & 21/10 mg | ER Capsules | Namzaric | Forest Laboratories LLC | CNS Agent |
7 | Fesoterodine | 4, 8mg | ER tablets | Toviaz | Pfizer | Overeactive bladder |
8 | Felodipine | 2.5 mg, 5 mg, or 10 mg | ER tablets | Plendil | AstraZeneca LP | Antihypertensive |
9 | Metformin | 500, 1000mg | XR tablets | Glucophage | Bristol Myers Squibb | Anti diabetic |
10 | Minocycline | eq.to base 55, 65, 105, 115mg | ER tablets | Solodyn | Medicis | Anti inflammatory |
11 | Memantine HCl | 7 mg/14 mg /21 mg/28 mg | ER Capsules | Namenda XR | Forest Laboratories | CNS |
12 | Propranolol | 60, 80, 120, 160mg | ER tablets | Inderal LA | Akrimax Pharms | Hypertension |
13 | Pramipexole | 0.375, 0.75, 1.5, 2.25, 3, 3.75, 4.5mg | ER tablets | Mirapex ER | Boehringer Ingelheim | Parkinson's disease |
14 | Oxybutinin | 5, 10, 15mg | ER tablets | Ditropan XL | Ortho Mc Neil Janssen | Overeactive bladder |
15 | Dalfampridine | 10 mg | ER Tablets | Ampyra | Acorda Therapeutics | CNS Agent |
16 | Mesalamine DR | 375 mg | DR Capsules | Apriso | Valeant Pharmaceuticals | Gastrointestinal |
17 | Ranolazine | 500mg, 1000mg | ER Tablets | Ranexa® | Gilead Sciences Inc | Antianginals |
18 | Pregabalin | 25mg,50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg | ER Capsules | Lyrica® | PF Prism CV | Antiepileptic agent |
19 | Glipizide | 2.5mg, 5.0mg,10mg | ER Tablets | Glucotrol XL® Tabs | Pfizer | Anti diabetic |
20 | Dexlansoprazole | 30mg, 60mg | DR Capsules | Kapidex® | Takeda Pharmaceuticals USA Inc | For GERD |
21 | Memantine | 7mg,14mg, 21mg, 28mg | ER Capsules | Namenda XR® | Forest Laboratories LLC | NMDA receptor antagonist |
SR. NO. | Generic | Strengths | Dosage form | Brand | Innovator | Therapeutic category |
---|---|---|---|---|---|---|
1 | Donepezil HCl | 5 and 10 mg | ODT | Aricept | Eisai Inc.(Pfizer) | Treatment of dementia of the Alzheimer's type |
2 | Rizatriptan benzoate | 5 and 10mg | ODT | Maxalt - MLT | Merck | Migraine |
3 | Lamotrigine | 25, 50 and 100mg | CD tablets | Lamictal | Glaxosmithkline LLC | Antiepileptic |
SR. NO. | Generic | Strengths | Dosage form | Brand | Innovator | Therapeutic category |
---|---|---|---|---|---|---|
1 | Tacrolimus | Eq. to 5mg/ml | Injection | Prograf | Astellas | Cytotoxic immunosuppressants |
2 | Adenosine | 3mg/ml | Injection | Adenocard | Astellas | Antiarrythmic (CVS) |
3 | Caffeine citrate | Eq 30mg base/3ml | Injection | Cafcit | Eurohealth Intl Sarl | Treat breathing problem |
4 | Colistimethate | Eq 500mg base/vial | Injection | Coly-mycin M | Par sterile products | Macrolide antibiotic |
5 | Levetiracetam | 500mg/5ml | Injection | Keppra | UCB Inc | Antiepileptic |
6 | Mycophenolate | 500mg/vial | Injection | Cellcept | Roche Palo | Cytotoxic immunosuppressants |
7 | Oxytocin | 10USP units/ml, 100USP units/10ml, 300USP units/30ml | Injection | Oxytocin | Fresenius Kabi | Uterine stimulant |
8 | Octreotide acetate | Eq. 1mg base/ml, Eq. 5mg base/ml | Injection | Octreotide | Eurohealth Intl Sarl | Suppress secretion of GH growth hormone |
9 | Protamine sulphate | 10mg/ ml | Injection | Protamine sulphate | Fresenius Kabi | Coagulant |
SR. NO. | Generic | Strengths | Dosage form | Brand | Innovator | Therapeutic category |
---|---|---|---|---|---|---|
1 | Amantadine | 100mg | Soft Gel | Amantadine HCl | Upsher-smith Laboratories, Inc (Sandoz) | Influenza |
2 | Benzonatate | 100, 200mg | Soft Gel | Benzonatate | The Pharma Network | Antitussive |
3 | Calcitriol | 0.25, 0.5mcg | Soft Gel | Rocaltrol | Validus Pharms | Hypocalcemia |
4 | Cetrizine | 10mg | Soft Gel | Zyrtec Allergy liquid Gels | Banner | Allergic Disorder |
5 | Dutasteride | 0.5mg | Soft Gel | Avodart | GSK | BPH |
6 | Ethosuximide | 250mg | Soft Gel | Zarontin | Parke Davis | Antiepileptic |
SR. NO. | Generic | Strengths | Dosage form | Brand | Innovator | Therapeutic category |
---|---|---|---|---|---|---|
1 | Fluticasone Propionate | 0.22mg/Inh, 0.11mg/Inh, 0.044mg/Inh | Aerosol, Metered | FLOVENT HFA | GSK | AntiInflammatory |
2 | Desmopressin | 0.01mg/Spray | Spray, Metered | DDAVP | Ferring | Antidiuretic |
3 | Desmopressin | 0.01mg/Spray | Spray, Metered | Minirin | Ferring | Antidiuretic |
4 | Olopatadine | 0.665mg/Spray | Spray, Metered | Patanase | Novartis | Antiallergic |
5 | Fluticasone Furoate | 0.0275mg/Spray | Spray, Metered | Flonase Sensimist Allergy Relief | GSK | AntiInflammatory |
6 | Albuterol Sulfate | 0.09mg /Inh | Aerosol, Metered | Ventolin HFA | GSK | Bronchodilator |
7 | Mometasone | EQ 0.05mg Base/Spray | Spray, Metered | Nasonex | Merck Sharp and Dohme Corp | AntiInflammatory |
8 | Mometasone | 0.10MG/Inh, 0.20MG/Inh | Aerosol, Metered | Asmanex HFA | Merck Sharp and Dohme Corp | AntiInflammatory |
SR. NO. | Generic | Strengths | Dosage form | Brand | Innovator | Therapeutic category |
---|---|---|---|---|---|---|
1 | Clonidine | 0.1mg/24hr, 0.2mg/24hr, 0.3mg/24hr | Film, ER | Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3 | Boehringer Ingelheim | Antihypertensives |
2 | Lidocaine | 5% | Patch | Lidoderm | Teikoku Pharma USA Inc | Anesthetic |
3 | Rivastigmine | 4.6 mg/24 hr, 9.5 mg/24 hr, 13.3 mg/24 hr | Film, ER | Exelon | Novartis | Parasympathomimetics |
4 | Estradiol | 0.0375mg/24Hr, 0.05mg/24Hr, 0.075mg/24Hr, 0.025mg/24Hr, 0.1mg/24Hr | Film, ER | Vivelle-Dot | Novartis | Estrogens |
© Copyrights 2021 KRV Pharma | Web Development by MagicWorks